Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma.

MLA

Prosz, Aurel, et al. “Nucleotide Excision Repair Deficiency Is a Targetable Therapeutic Vulnerability in Clear Cell Renal Cell Carcinoma.” BioRxiv : The Preprint Server for Biology, Feb. 2023. EBSCOhost, https://doi.org/10.1101/2023.02.07.527498.

APA

Prosz, A., Duan, H., Tisza, V., Sahgal, P., Topka, S., Klus, G. T., Börcsök, J., Sztupinszki, Z., Hanlon, T., Diossy, M., Vizkeleti, L., Stormoen, D. R., Csabai, I., Pappot, H., Vijai, J., Offit, K., Ried, T., Sethi, N., Mouw, K. W., … Szallasi, Z. (2023). Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma. BioRxiv : The Preprint Server for Biology. https://doi.org/10.1101/2023.02.07.527498

Chicago

Prosz, Aurel, Haohui Duan, Viktoria Tisza, Pranshu Sahgal, Sabine Topka, Gregory T Klus, Judit Börcsök, et al. 2023. “Nucleotide Excision Repair Deficiency Is a Targetable Therapeutic Vulnerability in Clear Cell Renal Cell Carcinoma.” BioRxiv : The Preprint Server for Biology, February. doi:10.1101/2023.02.07.527498.